Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KRN125 vs KRN8601 for chemotherapy-induced neutropenia in elderly non-Hodgkin's lymphoma
jRCT2080221502Phase 3
- Sponsor
- Kyowa Kirin
- Start
- Jun 2011
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of pegfilgrastim in non-Hodgkin lymphoma (NHL) and chemotherapy-induced neutropenia (CIN) (2 arms), sponsored by Kyowa Kirin.
02
Drugs
pegfilgrastim
03
Conditions
non-Hodgkin lymphoma (NHL)chemotherapy-induced neutropenia (CIN)
Beyond the preview
Go deeper on jRCT2080221502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221502.